A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
PHASE3CompletedINTERVENTIONAL
Enrollment
641
Participants
Timeline
Start Date
January 31, 2000
Study Completion Date
December 31, 2000
Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG
Risperidone Long acting injectable
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT00249223 - A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia | Biotech Hunter | Biotech Hunter